Volume of distribution (L/kg)       :–
half-life – normal/ESRD (hrs)      :–
DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
20 to 50     : Dose as in normal renal function
10 to 20     : Dose as in normal renal function
<10           : Dose as in normal renal function
DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Unknown dialysability. Dose as in normal renal function
HD                     :Unknown dialysability. Dose as in normal renal function
HDF/high flux   :Unknown dialysability. Dose as in normal renal function
CAV/VVHD      :Unknown dialysability. Dose as in normal renal function
IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugs
Ciclosporin: concentration of ciclosporin increased
Anticoagulants: antagonism of anticoagulant effect of coumarins and phenindione
Anti-epileptics: accelerate metabolism of oestrogens
ADMINISTRATION
Reconstition
To 50 mL with sodium chloride 0.9%
Route
IV
Rate of Administration
Over a minimum of 30 minutes
Comments
–
OTHER INFORMATION
Duration of effect about 14 days Used in association with desmopressin (DDAVP) in intractable casesOrally
10 to 20     : mg daily for 5–7 days Conjugated oestrogens are a mixture of sodium oestrone sulphate and sodium equilin sulphate and other oestrogenic substances of the type excreted by pregnant maresoestrogen, conjugated (unlicensed product).